Mrv0541 05041208332D 10 10 0 0 0 0 999 V2000 0.0000 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7145 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7145 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 0.4125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 1.6500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.4991 0.6674 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.4991 -0.6674 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.9840 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0 0 0 0 2 8 1 0 0 0 0 3 2 2 0 0 0 0 3 9 1 0 0 0 0 1 4 2 0 0 0 0 4 5 1 0 0 0 0 5 7 2 0 0 0 0 6 5 1 0 0 0 0 10 8 2 0 0 0 0 10 9 1 0 0 0 0 M END > DB01971 > drugbank > OC(=O)\C=C\C1=CNC=N1 > InChI=1S/C6H6N2O2/c9-6(10)2-1-5-3-7-4-8-5/h1-4H,(H,7,8)(H,9,10)/b2-1+ > LOIYMIARKYCTBW-OWOJBTEDSA-N > C6H6N2O2 > 138.124 > 138.042927446 > 3 > 16 > -0.880509044827026 > 13.09524481706865 > 1 > 2 > 0 > 0 > (2E)-3-(1H-imidazol-4-yl)prop-2-enoic acid > 0.22 > -1.0248030891020588 > -0.51 > 0 > -1 > 1 > -1 > 13.886392712794628 > 3.655908727603202 > 6.132312452477085 > 65.97999999999999 > 35.5676 > 2 > 1 > 4.25e+01 g/l > tetrahydrofolic acid > 0 > DB01971 > EXPT03207 > experimental > trans-urocanic acid > (2E)-3-(1H-imidazol-4-yl)acrylic acid; (E)-3-(1H-imidazol-4-yl)-2-propenoic acid; Urocanic acid $$$$